1. Home
  2. ICVX

ICVX

Icosavax Inc.

Logo Icosavax Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

0

Icosavax Inc is a biopharmaceutical company. It is committed towards developing safe and effective vaccines against infectious diseases against infectious diseases, with an initial focus on life-threatening respiratory diseases.

Founded: 2017 Country:
United States
United States
Employees: N/A City: SEATTLE
Market Cap: 769.0M IPO Year: 2021
Target Price: $25.00 AVG Volume (30 days): 1.2M
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.22 EPS Growth: N/A
52 Week Low/High: $4.75 - $16.11 Next Earning Date: 03-28-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: